Haemonetics Corporation
NYSE:HAE · New York Stock Exchange
+$0.84 today
Vol 0.89M · Avg 0.88M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+2.91%
Period High
$87.16
Period Low
$47.67
Latest
$74.17
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.65B
Beam Therapeutics Inc.
NASDAQ:BEAM
$3.38B
Integer Holdings Corporation
NYSE:ITGR
$3.08B
Warby Parker Inc.
NYSE:WRBY
$3.07B
Premier, Inc.
PINC
$2.34B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.14B
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
$2.04B
Bausch Health Companies Inc.
NYSE:BHC
$1.71B
QuidelOrtho Corporation
NASDAQ:QDEL
$903.87M
What is the latest HAE filing?
The latest filing shown is DEF 14A dated Jun 9, 2026.
How many recent filings does HAE have?
Intrinsic Alpha currently shows 20 recent filings for HAE.
Explore More
Continue the stock analysis
Jump to another research area for this company.